[BDRX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Mar-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -32.78%
YoY- 2.92%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 116 116 234 234 89 89 201 -30.61%
PBT -2,545 -2,545 -1,699 -1,699 -1,358 -1,358 -1,695 31.02%
Tax 248 248 169 169 205 205 118 63.85%
NP -2,298 -2,298 -1,531 -1,531 -1,153 -1,153 -1,577 28.44%
Tax Rate - - - - - - - -
Total Cost 2,413 2,413 1,765 1,765 1,242 1,242 1,778 22.51%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -1,989.18 -1,989.18 -654.06 -654.06 -1,302.82 -1,302.82 -786.53 85.31%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -185.31 -185.31 -124.33 -124.33 -94.32 -94.32 0.00 -
EPS Diluted -185.31 -185.31 -124.33 -124.33 -94.32 -94.32 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.